Cargando…

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?

Detalles Bibliográficos
Autores principales:	Gawałko, Monika, Jespersen, Thomas, Dobrev, Dobromir, Linz, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452559/ https://www.ncbi.nlm.nih.gov/pubmed/32885798 http://dx.doi.org/10.1016/j.ijcha.2020.100581

Ejemplares similares

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?
por: Gawałko, Monika, et al.
Publicado: (2020)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2022)

Does weight matter in cryoballoon ablation?
por: Gawałko, Monika, et al.
Publicado: (2023)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge
por: Linz, Dominik, et al.
Publicado: (2021)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies
por: Huang, Rui, et al.
Publicado: (2021)

A call for a more objective and longitudinal reporting of lifestyle components in cardiovascular research
por: Gawałko, Monika, et al.
Publicado: (2020)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept
por: Linz, Benedikt, et al.
Publicado: (2020)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic
por: Linz, Dominik, et al.
Publicado: (2021)

Recent highlights on the prevalence and role of sleep disordered breathing in cardiovascular diseases from the International Journal of Cardiology Heart & Vasculature
por: Linz, Dominik, et al.
Publicado: (2023)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
por: Rio, Daniele Del, et al.
Publicado: (2017)

Direct oral anticoagulation and severe obesity – One size fits all?
por: Fender, Anke C., et al.
Publicado: (2021)

Trimethylamine N-oxide in atrial fibrillation progression
por: Büttner, Petra, et al.
Publicado: (2020)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

The impact of an atrial septal defect on the progression of atrial tachypacing-induced atrial fibrillation in a Danish Landrace pig: A case report
por: Saljic, Arnela, et al.
Publicado: (2022)

The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023)

Botulinum toxin for prevention of post-operative atrial fibrillation
por: Saljic, Arnela, et al.
Publicado: (2023)

Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014)

Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs?
por: Linz, Dominik, et al.
Publicado: (2018)

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
por: Dobrev, Dobromir, et al.
Publicado: (2022)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention
por: Chang, Yu-Chun, et al.
Publicado: (2021)

Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously hypertensive rats
por: Linz, Benedikt, et al.
Publicado: (2020)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2023)

Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
por: Chen, Gong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cl9e0cihf6n79pl2uni9osdu9l